Yahoo Web Search

Search results

1. • 

     Obsidian’s Avowed Gets New Story Trailer, Still No Release Date - Xbox Games Showcase 2024 - IGN

     IGN Videogames· 5 days ago

     "Explore the Living Lands, a mysterious island filled with adventure and danger," Avowed's story...

2. • 

     Health Benefits of Lychee

     Health via Yahoo News· 5 days ago

     Lychee is a subtropical fruit with a sweet, berry-like taste. They're high in antioxidants and anti-inflammatory compounds and may support heart health.

3. • How Cinnamon Can Benefit Your Health

     Mercola· 3 days ago

     Maharishi Ayurveda Products International (MAPI) notes that cinnamon is often used for Ayurvedic recipes to enhance the bioavailability of other herbs while combining a delicious mixture of ...

4. • 

     ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy

     BioPharma-Reporter· 4 days ago

     The US firm AffyImmune Therapeutics discusses how its donor cell-derived candidate could address...

5. • 

     10 Best Supplements to Take in the Summer, Doctors Say — Best Life

     Best Life· 6 days ago

     For instance, as the summer brings excessive heat and damaging UV rays, you can assume your skin,...

6. • Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May

     ETF DAILY NEWS· 2 days ago

     Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...

7. • Ruvidar(TM) Enhances Efficacy of Cancer Drug

     The Joplin Globe· 5 days ago

     TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...

8. • Ruvidar(TM) Enhances Efficacy of Cancer Drug

     Digital Journal· 5 days ago

     TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...

9. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 5 days ago

     J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study PR Newswire SEOUL, South Korea, June 10, 2024 SEOUL, South Korea, June 10, 2024 /PRNewswire/ --